Severe HDN due to anti-Ce that required exchange tranfusion

Transfusion. 2000 May;40(5):571-4. doi: 10.1046/j.1537-2995.2000.40050571.x.

Abstract

Background: Rh system antibodies are commonly encountered in blood bank practice as well as during pregnancy. Nevertheless, no examples of anti-Ce (RH7) have been reported as a cause of HDN that requires exchange transfusion.

Case report: A 38-year-old woman in her fourth pregnancy was typed as blood group O D+, C-, c+, E+, e-. Anti-C and anti-e were detected in her serum during a routine prenatal work-up. Further evaluation, including flow cytometric analysis, revealed the presence of a strong anti-Ce and a weak anti-e. Her partner was typed as group A D+, C+, c-, E-, e+. A seemingly healthy male infant was delivered at 40 weeks of gestation. The infant's RBCs were typed as group O D-, C+, c+, E+, e+ with a positive DAT (titer 128). Twenty-five hours after birth, the baby had to be transferred to the neonatal intensive care unit because of rapidly rising total serum bilirubin. Despite intensive treatment, including double phototherapy, albumin infusion, and the administration of furosemide and IVIG, the total serum bilirubin level increased during the following day and exchange transfusion with 2 units of type O D-, C-, c+, E+, e- had to be performed; this resulted in a prompt decrease in total serum bilirubin without relapse.

Conclusion: Anti-Ce caused severe HDN requiring exchange transfusion. This highlights the need for a close follow-up throughout pregnancy if unexpected RBC antibodies are present, to permit the provision of compatible blood in case of a rare antibody.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibody Specificity
  • Coombs Test
  • Exchange Transfusion, Whole Blood*
  • Female
  • Flow Cytometry
  • Haplotypes
  • Humans
  • Infant, Newborn
  • Isoantibodies / immunology
  • Male
  • Pregnancy
  • Rh-Hr Blood-Group System / genetics
  • Rh-Hr Blood-Group System / immunology
  • Vitamin K Deficiency Bleeding / immunology*
  • Vitamin K Deficiency Bleeding / therapy*

Substances

  • Isoantibodies
  • Rh-Hr Blood-Group System